If You Don’t Know Which Lab To Order, You’ve Already Lost The Framework

Lab selection isn’t a research task. It’s a clinical output. The moment you’re uncertain which panel to run, the problem isn’t the lab — it’s that you’re working backwards from symptoms instead of forwards from a framework.

I get this question a lot. “Which lab should I run first?” Or its close relative: “Should I start with a DUTCH or a GI Map? Is blood work enough, or do I need organics as well?”

And I understand why practitioners ask it. Lab companies are good at marketing. There are a lot of panels available. And in the absence of a clear framework, the question feels like a reasonable place to start.

It isn’t.

The question of which lab to order is not where clinical reasoning begins. It’s where it arrives — after everything else has already been done. If you’re starting there, you’ve already left the framework behind.

The lab is the answer to a question you haven’t asked yet

Think about how functional medicine is supposed to work. You take a full history. You look at the timeline — when did this start, what happened just before, what’s been accumulating over time. You build a picture of terrain: gut function, hormone status, inflammatory load, toxic burden, nervous system tone.

From that picture, you form a hypothesis. And the lab’s job is to confirm, refute, or refine that hypothesis.

The lab is not the starting point. It’s the instrument you pick up once you already have a clinical direction.

When practitioners ask “which lab should I run?” without doing that prior work, what they’re really telling me is: I haven’t built a clinical picture yet. I’m hoping the lab will build it for me. It won’t. That’s not what labs are for.

What happens when you lose the framework

When the framework goes, something very specific happens. You stop looking upstream and start looking at symptoms.

Patient has fatigue, brain fog, and low libido. You think “homones.” So you order a DUTCH. It comes back showing low progesterone, elevated cortisol. You start addressing hormones.

Three months later the patient is marginally better but the pattern keeps returning. You retest. Still dysregulated. You try a different protocol. Still dysregulated. The problem isn’t the protocol. The problem is that you’re treating the output of a dysfunctional system as if it’s the root of the problem.

WHAT’S ACTUALLY HAPPENING:

Hormones don’t dysregulate randomly. There’s almost always something upstream — a pathogen load driving inflammatory signalling, a gut environment producing LPS and systemic immune activation, a drainage problem keeping the body in a low-grade crisis state. Until you deal with that, the hormone pattern will keep reasserting itself. You can modulate it temporarily.

You cannot resolve it.

And the only way to see that upstream picture clearly is to have started there — which means having a framework that told you to look there before you ever picked up a lab panel.

The analogy that makes this concrete

Imagine you’re a mechanic. A car comes in. The check engine light is on, there’s a slight rattle under the bonnet, and fuel consumption is higher than it should be.

Now imagine you skip the diagnostic read and go straight to replacing parts. You change the air filter because that’s what came up last time with these symptoms. The car runs better for a week. Then the rattle is back.

The issue was never the air filter. The issue was a failing fuel injector causing incomplete combustion — which was stressing the oxygen sensors, tripping the engine management system, and producing every symptom you were treating.

The diagnostic read would have told you that immediately. But you didn’t start with the diagnostic read. You started with the symptoms.

That’s exactly what happens when a practitioner opens with the lab question. They’re replacing the air filter when the problem is in the fuel line.

What the framework actually tells you

A proper clinical framework answers the lab question before you even have to ask it. It tells you where in the sequence you are. It tells you which terrain is the priority — not because of the patient’s chief complaint, but because of how the body’s systems interact and in what order they need to be addressed.

For example: if you’re working within a framework that sequences clearance before optimisation, you already know that the first priority is identifying what’s producing the chronic burden — pathogens, inflammatory drivers, drainage dysfunction. That hypothesis tells you which panel to run. Not because you looked up what panel matches the symptoms. Because the framework generated the question, and the question determined the lab.

Sequencing matters here too. You don’t run a comprehensive hormone panel on someone whose gut is in active inflammatory crisis, because you won’t be able to interpret it cleanly. The downstream disruption from the gut will be confounding the hormone picture. You’ll treat based on a signal that isn’t stable. You’ll be treating the wrong thing.

Framework first. The lab becomes obvious. It’s not a research task — it’s a clinical output.

Why this pattern is so common

The training most practitioners receive is comprehensive on biochemistry and incomplete on clinical sequencing. You come out of a functional medicine programme knowing a great deal about the gut-hormone axis, the methylation cycle, the HPA, mitochondrial function. The science is solid.

What most programmes don’t give you is a decision architecture. A framework that says: given this presentation, these are the priorities, in this order, and here’s why. Most leave you with the knowledge and ask you to assemble the framework yourself.

So practitioners fall back on what’s available — case studies, protocols from conferences, what they’ve heard others doing, what lab companies recommend. All of which starts from symptoms and works backwards.

It’s not a knowledge gap. It’s a framework gap. And the two are very different problems with very different solutions.

Four questions to answer before you think about a panel

Work through these in order. When you can answer all four, the lab selection is no longer a question.

• What is the primary terrain disruption in this patient right now? Gut, pathogen burden, hormone axis, detox capacity, or nervous system tone?

• What does the timeline tell me about which terrain came first — and which disruptions are likely downstream consequences of it?

• Is this patient’s drainage and detox capacity open enough to begin addressing the primary terrain? Or does that need to come first?

• What specific question am I trying to answer with a lab — and which panel answers that question most precisely?

When you answer those in order, the lab question answers itself. You’re not choosing between panels based on what sounds comprehensive. You’re running the panel that corresponds to the specific question your framework generated. That’s functional medicine practised as a methodology, not as a collection of tests.

The uncomfortable truth

If you find yourself regularly unsure which lab to run, the solution is not a better lab guide or a new testing algorithm. The solution is getting clear on the clinical framework that makes the selection obvious.

The lab question is downstream of everything. When the upstream work is done — when you have a clear model, a clear sequence, and a clear understanding of what you’re looking for and why — there’s no uncertainty about which panel to run. The uncertainty is a signal. Pay attention to it.

If you’re a licensed health professional who has the clinical knowledge and is looking for the framework that makes it actionable — including the case mentorship that makes that framework work in real patients — that’s exactly what we built at FMFT. You can read more at functionalmedicinefasttrack.com.